Apixaban vs rivaroxaban in patients with atrial fibrillation

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2020年 / 1796卷 / 1期
关键词：
D O I：
10.1007/s40278-020-76294-7
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：7 / 7
相关论文
共 50 条
  • [21] Changing anticoagulant paradigms for atrial fibrillation: dabigatran, apixaban and rivaroxaban
    Giorgi, Mariano A.
    Cohen Arazi, Hernan
    Gonzalez, Claudio D.
    Di Girolamo, Guillermo
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (04) : 567 - 577
  • [22] Apixaban in Patients with Atrial Fibrillation
    Owen, Andrew
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (24): : 2363 - 2363
  • [23] Apixaban in Patients with Atrial Fibrillation
    Connolly, Stuart J.
    Eikelboom, John
    Joyner, Campbell
    Diener, Hans-Christoph
    Hart, Robert
    Golitsyn, Sergey
    Flaker, Greg
    Avezum, Alvaro
    Hohnloser, Stefan H.
    Diaz, Rafael
    Talajic, Mario
    Zhu, Jun
    Pais, Prem
    Budaj, Andrzej
    Parkhomenko, Alexander
    Jansky, Petr
    Commerford, Patrick
    Tan, Ru San
    Sim, Kui-Hian
    Lewis, Basil S.
    Van Mieghem, Walter
    Lip, Gregory Y. H.
    Kim, Jae Hyung
    Lanas-Zanetti, Fernando
    Gonzalez-Hermosillo, Antonio
    Dans, Antonio L.
    Munawar, Muhammad
    O'Donnell, Martin
    Lawrence, John
    Lewis, Gayle
    Afzal, Rizwan
    Yusuf, Salim
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (09): : 806 - 817
  • [24] Hemostasis POC tests are affected by dabigatran, rivaroxaban and apixaban treatments in patients with atrial fibrillation
    Paniccia, R.
    Marcucci, R.
    Priora, R.
    Liotta, A. Alessandrello
    Poli, D.
    Lembo, G.
    Ahmed, Y.
    Fanciullacci, C.
    Pazzi, M.
    Abbate, R.
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 : 1080 - 1080
  • [25] Comparative Effectiveness of Dabigatran, Rivaroxaban, Apixaban, and Warfarin in the Management of Patients With Nonvalvular Atrial Fibrillation
    Pink, J.
    Pirmohamed, M.
    Hughes, D. A.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 94 (02) : 269 - 276
  • [26] New Anticoagulants (Dabigatran, Apixaban, Rivaroxaban) for Stroke Prevention in Atrial Fibrillation
    Aguilar, Maria I.
    Kuo, Ruth S.
    Freeman, William D.
    [J]. NEUROLOGIC CLINICS, 2013, 31 (03) : 659 - +
  • [27] COST EFFECTIVENESS OF APIXABAN, DABIGATRAN RIVAROXABAN AND WARFARIN FOR ATRIAL FIBRILLATION IN GUATEMALA
    Garita, M.
    Peralta, M.
    Gordillo, D., I
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A115 - A115
  • [28] Meta-Analysis Comparing Apixaban Versus Rivaroxaban for Management of Patients With Nonvalvular Atrial Fibrillation
    Mamas, Mamas A.
    Batson, Sarah
    Pollock, Kevin G.
    Grundy, Sarah
    Matthew, Andrew
    Chapman, Chris
    Manuel, Joana Assis
    Farooqui, Usman
    Mitchell, Stephen A.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2022, 166 : 58 - 64
  • [29] A Comparison of Bleeding Events Among Patients on Apixaban, Rivaroxaban, and Warfarin for Atrial Fibrillation and/or Venous Thromboembolism
    Schaefer, Jordan K.
    Errickson, Josh
    Kong, Xiaowen
    Ali, Mona A.
    Chipalkatti, Naina
    Haymart, Brian
    Kaatz, Scott
    Krol, Gregory D.
    Sood, Suman L.
    Froehlich, James
    Barnes, Geoffrey D.
    [J]. BLOOD, 2023, 142
  • [30] Effectiveness and Safety of Apixaban Compared With Rivaroxaban for Patients With Atrial Fibrillation in Routine Practice A Cohort Study
    Fralick, Michael
    Colacci, Michael
    Schneeweiss, Sebastian
    Huybrechts, Krista F.
    Lin, Kueiyu Joshua
    Gagne, Joshua J.
    [J]. ANNALS OF INTERNAL MEDICINE, 2020, 172 (07) : 463 - +
12345